These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36084986)

  • 1. Cardiovascular risk in type 1 and type 2 diabetes: Differences, similarities and insights.
    Victoria EOM; Doménech CV
    Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(7):455-457. PubMed ID: 36084986
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular Risk Stratification and its Determinants Among Patients with Type 2 Diabetes Mellitus.
    Deb P; Mohanty IR; Rai S
    J Assoc Physicians India; 2020 Mar; 68(3):90. PubMed ID: 32138498
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 2 diabetes-related sex differences in cardiovascular risk: reasons, ramifications, and clinical realities.
    Sattar N
    Eur Heart J; 2020 Apr; 41(13):1354-1356. PubMed ID: 31860071
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic retinopathy is also an important marker of cardiovascular risk in type 2 diabetes, with practical implications.
    Rigalleau V; Larroumet A; Mohammedi K; Baillet-Blanco L; Borderie G; Delyfer MN; Korobelnik JF; Foussard N
    Diabet Med; 2022 Aug; 39(8):e14845. PubMed ID: 35426164
    [No Abstract]   [Full Text] [Related]  

  • 5. Widespread diabetes screening for cardiovascular disease risk estimation.
    Arnett DK
    Lancet; 2021 Jun; 397(10291):2228-2230. PubMed ID: 34089657
    [No Abstract]   [Full Text] [Related]  

  • 6. Longitudinal audit of assessment and pharmaceutical intervention for cardiovascular risk in the Australasian Diabetes Data Network.
    Robertson CA; Earnest A; Chee M; Craig ME; Colman P; Barrett HL; Bergman P; Cameron F; Davis EA; Donaghue KC; Fegan PG; Hamblin PS; Holmes-Walker DJ; Jefferies C; Johnson S; Mok MT; King BR; Sinnott R; Ward G; Wheeler BJ; Zimmermann A; Jones TW; Couper JJ;
    Diabetes Obes Metab; 2022 Feb; 24(2):354-361. PubMed ID: 34713959
    [No Abstract]   [Full Text] [Related]  

  • 7. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population.
    Cebrián-Cuenca AM; Mata-Cases M; Franch-Nadal J; Mauricio D; Orozco-Beltrán D; Consuegra-Sánchez L
    Eur J Prev Cardiol; 2022 Feb; 28(18):e32-e34. PubMed ID: 33733654
    [No Abstract]   [Full Text] [Related]  

  • 8. Gender differences in cardiovascular risk profiles and diabetes care among adults with type 2 diabetes in Germany.
    Du Y; Baumert J; Paprott R; Neuhauser H; Heidemann C; Scheidt-Nave C
    Diabetes Metab; 2019 Apr; 45(2):204-206. PubMed ID: 29954666
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    Inzucchi SE; Peixoto AJ; Testani JM
    N Engl J Med; 2021 Aug; 385(7):669-670. PubMed ID: 34379938
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes. Reply.
    Kalyani RR
    N Engl J Med; 2021 Aug; 385(7):671-672. PubMed ID: 34379941
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk score for diabetic patients. Is really necessary?].
    Mostaza JM; Lahoz C
    Med Clin (Barc); 2006 Apr; 126(13):495-6. PubMed ID: 16624229
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular risk in children and adolescents with type 2 diabetes mellitus.
    Prendergast C; Gidding SS
    Curr Diab Rep; 2014 Feb; 14(2):454. PubMed ID: 24402326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Davis TM
    Intern Med J; 2010 Apr; 40(4):286-92. PubMed ID: 19323700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk stratification in type 2 diabetes.
    Esdaile H; Mayet J; Hill N
    Diabet Med; 2022 Oct; 39(10):e14922. PubMed ID: 35892178
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heart and diabetes: the number of high risk patients increases].
    Marx N
    Dtsch Med Wochenschr; 2015 Apr; 140(9):644. PubMed ID: 25924042
    [No Abstract]   [Full Text] [Related]  

  • 16. Unanswered questions arising from the continuous relationship between glucometabolic state and cardiovascular risk.
    Tonkin AM; Chen L
    Curr Atheroscler Rep; 2006 Nov; 8(6):439-40. PubMed ID: 17045067
    [No Abstract]   [Full Text] [Related]  

  • 17. Capsule Commentary for Raghavan et al., Association of Glycemic Control Trajectory with Short-term Mortality in Diabetes Patients with High Cardiovascular Risk: a Joint Latent Class Modeling Study.
    Blaszak SC; Nye DG; Walton HH
    J Gen Intern Med; 2020 Aug; 35(8):2518. PubMed ID: 32424784
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk in patients with type 2 diabetes: A systematic review of prediction models.
    Galbete A; Tamayo I; Librero J; Enguita-Germán M; Cambra K; Ibáñez-Beroiz B;
    Diabetes Res Clin Pract; 2022 Feb; 184():109089. PubMed ID: 34648890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition, obesity, diabetes, and cardiovascular outcomes: a deadly association.
    Lüscher TF
    Eur Heart J; 2020 Jul; 41(28):2603-2607. PubMed ID: 33216914
    [No Abstract]   [Full Text] [Related]  

  • 20. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation.
    Franjic B; Marwick TH
    J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.